Clinical Study On The Immune T Cells Of Cancer Patients After Chemotherapy With Direct Moxibustion On Zu Sanli And Qi Hai Poingts

Objective:To investigate the direct moxibustion Zusanli, the sea air affect the immune T cells in cancer chemotherapy patients after chemotherapy in cancer patients for clinical treatment of immune function, provide a reference and reference.Methods:All cases, a total of 60 cases, are between January 2015 and January 2015 in the second affiliated hospital of anhui medical university oncology patients in hospital.60 patients with tumor chemotherapy, according to the doctor order Numbers for 01-60, in accordance with the principle of random grouping, divided into treatment group and control group, 30 cases in each group.Treatment group: the standard chemotherapy +direct moxibustion, find out the foot three mile, air sea).Stay when shi jiu ai wick burning to about 2/5-1/5, patients feel hot not tolerance, timely replacement moxa wick,jiu zhuang, 5 consecutive 1 times a day, from patients with chemotherapy before 1 day,to the next chemotherapy for a period of treatment, a total of 30 days.Control group:chemotherapy, don't moxibustion.During the treatment, stop using other related treatment, all patients before treatment and after treatment for 1 time of peripheral blood test, for statistical data processing.Choose survival scale QLQ C30, CD4 +, CD8 + and Th17 cells as observation indexes, observe direct moxibustion foot three mile, qi hai effect on tumor chemotherapy in patients with immune T cells.Results1. The treatment group and control group, age, duration and sex, types of cancer patients, chi-square test, the difference was not statistically significant(P >0.05),prompted two groups were comparable.2. The treatment group and control group in the peripheral blood CD4 + content, before the treatment, comparing differences between groups have no statistical significance (P > 0.05), prompted two groups of comparable;CD4 + content increased after treatment,the treatment group, compare differences in the group have significant statistical significance(P<0.01);The control group, cut down the content of CD4+ group comparative difference was statistically significant(P<0.05);Comparison between groups, have significant statistical significance difference(P < 0.01).3. The treatment group and control group in the peripheral blood CD8 + content, before the treatment, comparing differences between groups have no statistical significance(P > 0.05), and suggests two groups of comparable;After treatment, the treatment group of CD8 + levels fell and compare differences in the group have significant statistical significance(P < 0.01);Control CD8 + content increased, the comparative differences had no statistical significance(P >0.05);Comparison between groups, have significant statistical significance difference(P < 0.01).4. The treatment group and control group in the peripheral blood Th17 expression level,before the treatment, comparing differences between groups have no statistical significance(P >0.05), prompted two groups of comparable;After treatment, the treatment group Th17 expression level decreased, compare differences in the group have significant statistical significance(P <0.01);Control group Th17 expression level decreased, group comparison difference was statistically significant(P <0.01);Comparison between groups, have significant statistical significance difference(P< 0.01).5. Before the treatment, the treatment group and control group patients' quality of life score, compare the differences between groups have no statistical significance(P >0.05), and suggests two groups of comparable;After treatment, the treatment group patients quality of life score increases, the control group patients quality of life scores decline, comparison between group and group difference was statistically significant(P< 0.05), suggesting the chemotherapy to cause a decline in quality of survival, and direct moxibustion can improve the quality of life of patients.Conclusion The results show that direct moxibustion may be elevated in patients with cancer chemo therapy peripheral blood CD4 + content, reduced CD8 + content and Th17 cells levels a nd improve immune function in cancer chemotherapy patients and improve quality of lif e, can be used as an adjunct to cancer patients after chemotherapy, improve the efficacy of chemotherapy. Research program is simple to operate, easy to grasp the patient can o perate on their own at home treatment. Not only reduce the financial burden on families,but also improve patient compliance. Direct moxibustion is safe and effective, simple a nd economical advantages, can reduce health care costs, with good economic and social benefits.